Stephen F. Mahoney - President and CEO, Director at Viridian Therapeutics, Inc.\DE

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
VRDN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen F. Mahoney since 12 Mar 2025

Holdings reported by Stephen F. Mahoney for Viridian Therapeutics, Inc.\DE

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 55,071 $1,718,949 $23.41 03 Mar 2026 Direct Common Stock
Common Stock 33,349 $1,002,470 $30.06 03 Mar 2026 Direct
Stock Option (Right to Buy) 559,600 02 Mar 2026 Direct Common Stock

Transactions reported by Stephen F. Mahoney for Viridian Therapeutics, Inc.\DE

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.